Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion

C Yıldırım - Molecular Biology Reports, 2024 - Springer
Leukemia is a malignancy of the bone marrow and blood originating from self-renewing
cancerous immature blast cells or transformed leukocytes. Despite improvements in …

[HTML][HTML] PD-L1 and PD-1 in Immune Regulation and Their Implications in Blood Cancers

PS Aghbash, F Mehdizadeh, G Porbeyragh… - Advances in Cancer …, 2024 - Elsevier
Because of emerging opportunities for cancer immunotherapy, the capacity to suppress the
immune system in order to cure and eradicate cancer is currently a topic of intense study …

[HTML][HTML] Identification of a Novel hsa_circ_0058058/miR-324-5p Axis and Prognostic/Predictive Molecules for Acute Myeloid Leukemia Outcome by Bioinformatics …

S Misir, S Ozer Yaman, N Petrović, A Šami, O Akidan… - Biology, 2024 - mdpi.com
Simple Summary Acute myeloid leukemia (LAML) is among the most common types of
hematological cancer. In recent years, it has been shown that circular RNA (circRNA) and …

Association of Polymorphisms in PD-1 and LAG-3 Genes with Acute Myeloid Leukemia

L Mansour, M Alqahtani, A Aljuaimlani, J Al-Tamimi… - Medicina, 2024 - mdpi.com
Background and objectives: Acute myeloid leukemia (AML) is a hematological malignancy
characterized by uncontrolled proliferation of immature myeloid cells. Immune checkpoint …

[PDF][PDF] International Journal of Veterinary Science

K Mukanov, K Mukantayev, K Tursunov - Int J Vet Sci, 2024 - ijvets.com
ABSTRACT A cluster of T-cell receptors includes activating and inhibitory stimulatory
molecules that favorably or unfavorably control immune responses. Recent studies on …